Seranova Bio, Inc.

SOUTH SAN FRANCISCO, CA · Founded 2020 · CIK 0001862032 · Biotech · Private

Platform identifying therapeutic antibody targets from natural autoantibody patterns in patient populations

seranovabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$15M
2 Form D · Feb 2024
32 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,049,990
Private capital raisedForm D · SEC$9,999,995
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3280ASKO THERAPEUTICS, INC.——
3281UNITED BIOTHERAPEUTICS LLC——
3282TARGETSITE THERAPEUTICS CORPORATION——
3283Seranova Bio, Inc.—$15M
3284NUBAD LLC——
3285NANOMATRONIX LLC——
3286PRECISION BIOTOOLS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Leon ChenDirector
  • Beatrice McQueenExecutive Officer
  • Sabah OneyDirector
  • Aaron RingDirector · Executive Officer
  • Damien SoghoianDirector · Executive Officer
  • Jim TananbaumDirector
  • Hui TianDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.